Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03639779 · ClinicalTrials.gov registry record · Phase 4
Efficacy of Intralesional Sodium Thiosulfate Versus Intralesional Saline for Dystrophic and Idiopathic Calcinosis Cutis
A Phase 4 study, sponsored by University of Central Florida.
- Terminated
- Registry status
- Phase 4
- Development phase
- 5
- Enrollment target
NCT03639779: Clinical Trial Phase 4 study, sponsored by University of Central Florida.
NCT03639779 is a Phase 4 study that was terminated before completion, run by University of Central Florida. The registered enrollment target is 5 participants, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (99% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03639779, a Phase 4 study, was terminated before completion, sponsored by University of Central Florida.
- TERMINATED
- Registry status
- Phase 4
- Development phase
- 5 participants
- Enrollment target
Study Summary
The purpose of our research is to compare the effectiveness of 125mg/50ml sodium thiosulfate (STS) solution to normal saline (0.9% sodium chloride) when injected intralesionally for the treatment of calcinosis cutis. Our specific aim is to assess the response of dystrophic and idiopathic calcinosis cutis to the injections of sodium thiosulfate in our patients.
Primary Outcome
The lesion size is measured in square centimeters.
Interventions
- OTHER Saline Solution
- DRUG Sodium Thiosulfate
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 5 participants |
| Start Date | 2018-11-02 |
| Est. Completion | 2019-12-31 |
| Phase | Phase 4 |
Why NCT03639779 stopped before completion
NCT03639779 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 5 participants, a relatively small participant target, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (99% lower).
The record links to 0 conditions, and to 2 interventions - of which Saline Solution is the first listed.
NCT03639779 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03639779 about?
NCT03639779 is a clinical study titled "Efficacy of Intralesional Sodium Thiosulfate Versus Intralesional Saline for Dystrophic and Idiopathic Calcinosis Cutis". The purpose of our research is to compare the effectiveness of 125mg/50ml sodium thiosulfate (STS) solution to normal saline (0.9% sodium chloride) when injected intralesionally for the treatment of calcinosis cutis. Our specific aim is to assess the response of dystrophic and idiopathic calcinosis ...
What is the current status of trial NCT03639779?
This trial is currently terminated. It is a Phase 4 study. The enrollment target is 5 participants. The study started on 2018-11-02. Estimated completion is 2019-12-31.
What interventions are being tested in trial NCT03639779?
The interventions under investigation include: Saline Solution (OTHER), Sodium Thiosulfate (DRUG).
Who is sponsoring clinical trial NCT03639779?
This trial is sponsored by University of Central Florida, which has 91 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT03639779's enrollment target sits among peer trials
5 1989th of 2000 higher than 7 of 2,000 other Phase 4 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 4 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI